Since the PI3K-AKT signaling pathway was found to be highly activated in the thyroid of these transgenic mice, the authors concluded that the enhanced AKT activity might have overwhelmed the AMPK-mediated action of metformin in the tumor cells. The gene discussed is AKT1; the disease is neoplasm.